The United States has decided to include Remadecivir in the investigational therapy of Kovid-19, given the increasing cases of corona infection and the critical condition. Remadecivir is used primarily by many countries.
The Food and Drug Administration Authority of the United States has approved the drug remedacevir to fight corona infection. According to the US media, Remedisivir will be given to people suffering from the corona virus.
Earlier, the US used the anti-malarial drug hydroxychloroquine to treat most of the hospital Kovid-19 patients. But it was discontinued when the results of its use were not correct.